SCHEMBL7040833

SCHEMBL7040833

COc1ccc(C(CN)C(=O)NCCc2ccccc2)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
POLB P06746 2/20 0.56
CTSD P07339 3/20 0.53
QPCT Q16769 1/20 0.53
ALDH1A1 P00352 3/20 0.53
PLAAT3 P53816 1/20 0.53
PLAAT5 Q96KN8 1/20 0.53
PLAAT2 Q9NWW9 1/20 0.53
PLAAT4 Q9UL19 1/20 0.53
TAAR1 Q96RJ0 1/20 0.52
TRPM5 Q9NZQ8 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4A O75164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7040630 0.88 F2 (0.54) RAB9ACTSDQPCTALDH1A1MAPT
SCHEMBL7040046 0.81 LMNA (0.55) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL6376353 0.80 POLB (0.68) POLBALDH1A1PLAAT3PLAAT5PLAAT2
SCHEMBL7038489 0.77 ACHE (0.59) POLBALDH1A1
SCHEMBL28196332 0.76 ACHE (0.49) NPC1RAB9APOLBALDH1A1
SCHEMBL20418416 0.76 ALDH1A1 (0.61) CTSDALDH1A1PLAAT3PLAAT5PLAAT2
SCHEMBL742343 0.76 KMT2A (0.71) ALDH1A1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL11001026 0.76 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HPGD
SCHEMBL28107955 0.75 EPHX1 (0.62) QPCTALDH1A1
SCHEMBL8098635 0.75 ALDH1A1 (0.62) CTSDALDH1A1PLAAT3PLAAT5PLAAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed